DE3875867D1 - Kalziumzusaetze. - Google Patents

Kalziumzusaetze.

Info

Publication number
DE3875867D1
DE3875867D1 DE8888201734T DE3875867T DE3875867D1 DE 3875867 D1 DE3875867 D1 DE 3875867D1 DE 8888201734 T DE8888201734 T DE 8888201734T DE 3875867 T DE3875867 T DE 3875867T DE 3875867 D1 DE3875867 D1 DE 3875867D1
Authority
DE
Germany
Prior art keywords
calcium
malate
calcium additives
citrate
additives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888201734T
Other languages
English (en)
Other versions
DE3875867T2 (de
Inventor
Stephen Allen Jacobs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Eaton Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharmaceuticals Inc filed Critical Norwich Eaton Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3875867D1 publication Critical patent/DE3875867D1/de
Publication of DE3875867T2 publication Critical patent/DE3875867T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8888201734T 1987-08-28 1988-08-15 Kalziumzusaetze. Expired - Lifetime DE3875867T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9081387A 1987-08-28 1987-08-28

Publications (2)

Publication Number Publication Date
DE3875867D1 true DE3875867D1 (de) 1992-12-17
DE3875867T2 DE3875867T2 (de) 1993-04-01

Family

ID=22224448

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888201734T Expired - Lifetime DE3875867T2 (de) 1987-08-28 1988-08-15 Kalziumzusaetze.

Country Status (13)

Country Link
EP (1) EP0304987B1 (de)
JP (1) JP2795651B2 (de)
KR (1) KR970009583B1 (de)
AT (1) ATE82120T1 (de)
AU (1) AU625809B2 (de)
CA (1) CA1314233C (de)
DE (1) DE3875867T2 (de)
DK (1) DK481388A (de)
HK (1) HK182096A (de)
IE (1) IE61452B1 (de)
IL (1) IL87452A (de)
NZ (1) NZ225950A (de)
ZA (1) ZA886355B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE121719T1 (de) * 1990-06-14 1995-05-15 Procter & Gamble Calciumcitrat/malat-gemisch.
CA2102210C (en) * 1991-05-06 1998-08-04 Mark Benson Andon Combined calcium and vitamin d supplements
CA2123604C (en) * 1991-12-26 1998-02-17 Alice Lyles Burkes Storage stable calcium-supplemented beverage concentrates
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
EP0788318B1 (de) * 1992-10-21 2000-12-20 The Procter & Gamble Company Konzentrierte, bioverfügbare kalziumquelle
WO1994008471A1 (en) * 1992-10-21 1994-04-28 The Procter & Gamble Company Sweetener containing a concentrated bioavailable calcium source
JP3199743B2 (ja) * 1992-10-21 2001-08-20 ザ、プロクター、エンド、ギャンブル、カンパニー カルシウムを補給した貯蔵安定な飲料用濃縮プレミックス及びシロップ
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
JPH09173020A (ja) * 1995-12-28 1997-07-08 Shiro Tanaka クエン酸・リンゴ酸カルシウムの可溶性濃厚カルシウム凍結品／冷蔵品およびその製造法
JP5140669B2 (ja) * 2006-08-17 2013-02-06 ザ プロクター アンド ギャンブル カンパニー クエン酸リンゴ酸カルシウムを含む組成物及びその製造方法
JP4762346B2 (ja) * 2006-08-17 2011-08-31 ザ プロクター アンド ギャンブル カンパニー クエン酸リンゴ酸カルシウムを含む組成物及びその製造方法
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
CN109568338A (zh) 2011-12-13 2019-04-05 艾玛菲克有限公司 用于治疗钙吸收不良和骨代谢紊乱的无定形碳酸钙
EP3302506A4 (de) 2015-06-04 2018-12-19 Amorphical Ltd. Zusammensetzungen von amorphem calciumcarbonat zur inhalation, sublingualen oder bukkalen verabreichung
AU2017349921B2 (en) 2016-10-25 2023-06-15 Amorphical Ltd Amorphous calcium carbonate for treating a leukemia
CN112137787B (zh) * 2020-09-16 2023-01-06 张宏伟 一种足踝外科下胫腓关节复位固定导向器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697248A (en) * 1979-12-28 1981-08-05 Tanaka Shiro Conjugated compound of calcium citrate and calcium malate and its preparation
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
CA1319612C (en) * 1987-07-02 1993-06-29 Haile Mehansho Iron-calcium mineral supplements with enhanced bioavailability
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements

Also Published As

Publication number Publication date
IE61452B1 (en) 1994-11-02
EP0304987A2 (de) 1989-03-01
JPH01156985A (ja) 1989-06-20
EP0304987A3 (en) 1990-02-21
IE882610L (en) 1989-02-28
HK182096A (en) 1996-10-11
AU2159888A (en) 1989-06-15
NZ225950A (en) 1991-10-25
IL87452A (en) 1992-07-15
AU625809B2 (en) 1992-07-16
DE3875867T2 (de) 1993-04-01
EP0304987B1 (de) 1992-11-11
IL87452A0 (en) 1989-01-31
KR890003391A (ko) 1989-04-14
DK481388A (da) 1989-03-02
DK481388D0 (da) 1988-08-29
ZA886355B (en) 1989-05-30
JP2795651B2 (ja) 1998-09-10
ATE82120T1 (de) 1992-11-15
CA1314233C (en) 1993-03-09
KR970009583B1 (en) 1997-06-14

Similar Documents

Publication Publication Date Title
DE3875867D1 (de) Kalziumzusaetze.
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
MY101934A (en) Composition useful for producing analgesia
NZ221424A (en) Pharmaceutical compositions contaipyrimidines
GB2259647B (en) Medicaments for treating gastrointestinal disorders
SE9002500L (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
IT8719048A0 (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DE3766885D1 (en) Chlorpheniramine therapie.
IT1224250B (it) Associzione del depiprazolo con la morfina
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
EP0316709A3 (en) Proteinaceous derivatives containing iron in highly bioaproteinaceous derivatives containing iron in highly bioavailable form, preparation thereof and pharmaceutical covailable form, preparation thereof and pharmaceutical compositions containing them mpositions containing them
ATE90942T1 (de) (3-diethylaminopropyl)-1-amino-5methyldipyrido(4,3-b>(3,4-f>indoltrihydrochlori .

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PROCTER & GAMBLE PHARMACEUTICALS, NORWICH, N.Y., U